Lifeway Foods Applauds New Research Examining Impact of Probiotics in Dairy Kefir on Microbiome in Children with ADHD

Lifeway Foods, Inc., a leading US supplier of kefir and fermented probiotic products that support the microbiome, applauds the recent study protocol titled, “Randomised controlled trial of the effects of kefir on behaviour, sleep and the microbiome in children with ADHD: a study protocol,” published by the British Medical Journal (BMJ) Open Journal. The trial will test diet-based intervention targeting gut health to support the wellbeing of children with ADHD, as previous research has suggested that daily consumption of the probiotics in dairy kefir can positively alter the composition of the microbiome, thus leading to a reduction in ADHD symptoms and improvements in sleep.

While additional research is needed, Lifeway is encouraged by the initial findings of a potential link between the probiotics and improvements in ADHD symptoms in children.

“At Lifeway Foods, it is our mission to help people live healthier, happier lives while providing the best in probiotic and nutritious foods,” said Julie Smolyansky, CEO of Lifeway Foods. “We continue to be inspired and reassured by the advancements in microbiome research and the positive effects of probiotic foods on mental and physical health. As the range of potential health benefits associated with probiotics continue to expand, we’re thrilled to be part of the path forward.”

As America’s leading supplier of kefir, Lifeway Kefir is made with 12 live and active cultures, and packed with protein, calcium and vitamin D. Each product is loaded with probiotics, which research suggests may help support the microbiome and may lead to positive improvements in gut and mental health.

To learn more about Lifeway and its products, visit lifewaykefir.com. To view the full study protocol published by BMJ open, click here.